RKDA

#4993
Arcadia Biosciences, Inc. - Common Stock
0.9 6 USD
0.00%
Secteur: Consommateur Défensif
Base: USD
Devise de Profit: USD
Range quotidien
0.96
0.96
Range Annuel
0.81
6.71
Changement quotidien
0.00%
Changement Mensuel
-5.88%
Evolution sur 6 mois
-73.18%
Changement Annuel
-80.12%
Clôture Précédente
0.9 6
Open
0.9 6
Low
0.9 6
High
0.9 6
Volume
2
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 1.97 M
  • Employee 8
  • Founded 2002
  • CEO N/A
  • Website www.arcadiabio.com
  • Headquarter Delaware, United States
  • FIGI BBG000GYBX66
  • Industry Aliments Emballés
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.16
ratio cours/chiffre d'affaires
0.53

Arcadia Biosciences, Inc. - Common Stock

Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation. It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.

Nouvelles